Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07251803 · ClinicalTrials.gov registry record
GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
A clinical trial of Gastric Retention, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07251803: Recruiting study of Gastric Retention, sponsored by Medical University of South Carolina.
NCT07251803 is a study of Gastric Retention that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07251803, a study of Gastric Retention, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll patients 18 years and older who are taking a GLP-1/GIP medication and 1) are scheduled for elective surgery and meet ASA fasting guidelines (nothing by mouth for at least 8 hours prior), or 2) scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior. Participants will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The purpose of this study is to determine if people taking GLP-1 receptor agonists and who fast normally are at an equal risk for having retained gastric contents after appropriately fasting for surgery, compared to patients who are on a liquid only diet for 24 hours prior to surgery.
Primary Outcome
While the patient is in supine position, the gastric volume will be measured via ultrasound and then calculated using a validated formula, GV (mL) = 27.0+(14.6\*CSA)-(1.28\*age).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Gastric Ultrasound
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2026-12-31 |
What NCT07251803 shows while recruiting
NCT07251803 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Gastric Retention appearing as the primary indexed condition, and to 1 intervention - of which Gastric Ultrasound is the first listed.
NCT07251803 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07251803 about?
NCT07251803 is a clinical study titled "GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound". This study will enroll patients 18 years and older who are taking a GLP-1/GIP medication and 1) are scheduled for elective surgery and meet ASA fasting guidelines (nothing by mouth for at least 8 hours prior), or 2) scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 ...
What is the current status of trial NCT07251803?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-02-03. Estimated completion is 2026-12-31.
What conditions does trial NCT07251803 study?
This clinical trial studies the following conditions: Gastric Retention.
What interventions are being tested in trial NCT07251803?
The interventions under investigation include: Gastric Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07251803?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07251803 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI